# Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine

## TL;DR

A new DNA vaccine using an altered SHIV backbone and apoptotic genes boosts immune responses, particularly CD8 T cells, in mice.

## Contribution

A novel single-cycle SHIV-based DNA vaccine with apoptotic genes is developed to enhance antigen-specific CD8 T-cell immunity.

## Key findings

- The CSH-DIN-T/F Z331-Cas8 vaccine induced higher proportions of IFN-γ-, IL-2-, and IL-21-producing CD8 T cells.
- Apoptotic gene incorporation increased immunogenicity through enhanced antigen cross-presentation.
- The vaccine demonstrated a single replication cycle and induced apoptosis in vitro.

## Abstract

HIV remains a major public health issue in spite of antiretroviral therapy (ART). An innovative vaccine that can induce long-lasting and effective immunity is required to curb the persistently high numbers of new infections worldwide.

A novel DNA vaccine was generated using a Simian-Human Immunodeficiency Virus (SHIV) backbone with a Zambian T/F clade C envelope and under the control of the caprine arthritis encephalitis virus long terminal repeats (LTRs) for constitutive expression. Due to the deleted integrase, this DNA vaccine “CSH-DIN-T/F Z331” performs only a single replication cycle. To increase immunogenicity, the co-expression of apoptotic genes (BAX, BAK, or caspase 8) incorporated at the end of Pol was tested to promote the release of apoptotic bodies taken up by dendritic cells leading to cross-presentation of antigen. The three vaccines (CSH-DIN-T/F Z331-BAX, CSH-DIN-T/F Z331-BAK, and CSH-DIN-T/F Z331-Cas8) were tested in vitro for expression and in vivo in BALB/cJ mice for immunogenicity.

Transduced HEK293 cells co-cultured with CEMx174 confirmed the single replication cycle of the DNA vaccine and the induction of apoptosis by CSH-DIN-T/F Z331-Cas8 based on Annexin V expression. BALB/cJ mice were immunized with a combined intramuscular + intradermal/electroporation approach. Intracellular cytokine staining (ICS) from splenocytes collected 12 weeks post-prime/6 weeks post-boost demonstrated a clear superiority of caspase 8 expressing construct over the others, with higher proportions of IFN-γ-, IL-2-, and IL-21-producing CD8 T cells specific to Env, Gag, and Nef. The kinetics of immune response after various immunization schedules were also investigated.

This novel single-cycle DNA vaccine with apoptotic genes demonstrated an enhanced immunogenicity primarily for antigen-specific CD8+ T-cell responses.